In an astonishingly short amount of time the Stall im Mölltal/Carinthia branch was developed into a production facility for concrete composite elements to be used in timber construction.
The plant expansion is mainly aimed at establishing a pioneering production plant for the manufacture of standard and custom building elements from cross laminated timber, for instance ready-to-install timber building elements for walls and ceilings.
Earthwork for the erection of the approx. 10,000 m² production hall has started in April of 2019. 10,000 m³ of fresh concrete were delivered to the Möll Valley and cast for foundation and cellar work. Adding to this are many pre-manufactured concrete elements for the 2,500 m² underground supply and collector ducts as well as the superstructure supports. The timber construction also boasted respectable quantities: HASSLACHER’s Hermagor/Carinthia location provided 1,000 m³ of glued laminated timber while the Magdeburg/Saxony-Anhalt delivered 1,300 m³ of glulam ceiling elements for the roof.
Project information | |
---|---|
Location: | Stall im Mölltal |
Architect/designer: | Trecolore Architects |
Structural analysis and construction: | Ingenieurbüro Bruno Kalles |
Client: | NORITEC Holzindustrie GmbH |
Year of construction: | 2019/2020 |
Products used: | Custom glued laminated timber elements, glulam ceiling elements |
Investments in the expansion of the Stall im Mölltal location will location will broaden the product range and increase the added value of our core range. In addition to 90,000 m² of earthmoving and 10,000 m³ of fresh concrete, 1,000 m³ of glued laminated timber special components and 1,300 m³ of glulam ceiling elements were required for the roof construction for the 10,000 m² production hall. This step will further strengthen our position as a leading innovator in cross-laminated timber production while simultaneously creating additional jobs and much needed apprenticeship positions in Upper Carinthia.
This project was partially funded by the European Regional Development Fund EFRE.